ISPE

OCTOBER 27, 2022

The term “DHTTs” is used to differentiate from the broader category of DHTs, but these two terms are often used interchangeably. As global health authorities develop DHTT regulatory requirements, they need to find the appropriate balance to foster innovation while maintaining product safety, efficacy, and quality. tools (DHTTs).

Health and Personal Care Stores 52

Health and Personal Care Stores FDA HIPAA Communication 52

ISPE

SEPTEMBER 11, 2023

Herein, DM refers to a manufacturing model in which many units or facilities are disseminated across different geographical areas 6 , 7 DM facilities may produce similar or identical products under a unified pharmaceutical quality system (PQS) or operate as independent units with different outputs.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MARCH 6, 2023

Challenges for Net Zero Carbon Pharmaceutical Manufacturing Trudy Patterson Mon, 03/06/2023 - 12:40 Features March / April 2023 Challenges for Net Zero Carbon Pharmaceutical Manufacturing Keith M. C global warming scenario by 2030, which is widely acknowledged to be necessary to avoid the worst impacts of climate change.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

MARCH 7, 2023

This article reviews two case studies that cover sustainable pack types and extension of shelf life. With the drive to manage unmet medical need through acceleration of drug development programs, postapproval sustainability variations will always be required. 1 Now there’s an additional focus: sustainability.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52